Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Daratumumab for eradication of minimal residual disease in high-risk advanced relapse of T-cell/CD19/CD22-negative acute lymphoblastic leukemia.

Ofran Y, Ringelstein-Harlev S, Slouzkey I, Zuckerman T, Yehudai-Ofir D, Henig I, Beyar-Katz O, Hayun M, Frisch A.

Leukemia. 2019 Aug 21. doi: 10.1038/s41375-019-0548-z. [Epub ahead of print] No abstract available.

PMID:
31435023
2.

Pro-inflammatory macrophages promote multiple myeloma resistance to bortezomib therapy.

Beyar-Katz O, Magidey K, Reiner-Benaim A, Barak N, Avivi I, Cohen Y, Timaner M, Avraham S, Hayun M, Lavi N, Bersudsky M, Voronov E, Apte RN, Shaked Y.

Mol Cancer Res. 2019 Aug 13. pii: molcanres.0487.2019. doi: 10.1158/1541-7786.MCR-19-0487. [Epub ahead of print]

PMID:
31409628
3.

Superior outcome of patients with favorable-risk acute myeloid leukemia using consolidation with autologous stem cell transplantation.

Beyar-Katz O, Lavi N, Ringelstein-Harlev S, Henig I, Yehudai-Ofir D, Haddad N, Fineman R, Ofran Y, Nov Y, Sahar D, Moustafa-Hawash N, Rowe JM, Zuckerman T.

Leuk Lymphoma. 2019 Apr 3:1-8. doi: 10.1080/10428194.2019.1594214. [Epub ahead of print]

PMID:
30943060
4.

Novel Approaches to Acute Myeloid Leukemia Immunotherapy.

Beyar-Katz O, Gill S.

Clin Cancer Res. 2018 Nov 15;24(22):5502-5515. doi: 10.1158/1078-0432.CCR-17-3016. Epub 2018 Jun 14. Review.

PMID:
29903894
5.

Primary Marginal Zone Lymphoma of the Lung and Organizing Pneumonia: A Diagnostic Challenge.

Corina Sela T, Beyar Katz O, Tadmor T, Bejar J, Schiff E.

Isr Med Assoc J. 2018 Mar;20(3):197-198. No abstract available.

6.

Therapy-Educated Mesenchymal Stem Cells Enrich for Tumor-Initiating Cells.

Timaner M, Letko-Khait N, Kotsofruk R, Benguigui M, Beyar-Katz O, Rachman-Tzemah C, Raviv Z, Bronshtein T, Machluf M, Shaked Y.

Cancer Res. 2018 Mar 1;78(5):1253-1265. doi: 10.1158/0008-5472.CAN-17-1547. Epub 2018 Jan 4.

7.

The Clinical Spectrum of Hepatic Manifestations in Chronic Lymphocytic Leukemia.

Kreiniz N, Beyar Katz O, Polliack A, Tadmor T.

Clin Lymphoma Myeloma Leuk. 2017 Dec;17(12):863-869. doi: 10.1016/j.clml.2017.07.008. Epub 2017 Jul 23. Review.

PMID:
28803824
8.

Empirical antibiotics targeting gram-positive bacteria for the treatment of febrile neutropenic patients with cancer.

Beyar-Katz O, Dickstein Y, Borok S, Vidal L, Leibovici L, Paul M.

Cochrane Database Syst Rev. 2017 Jun 3;6:CD003914. doi: 10.1002/14651858.CD003914.pub4. Review.

9.

Published abstracts at international meetings often over- or underestimate the initial response rate.

Beyar-Katz O, Rowe JM, Townsend LE, Tallman MS, Hadomi R, Horowitz NA.

Blood. 2017 Apr 20;129(16):2326-2328. doi: 10.1182/blood-2017-01-763144. Epub 2017 Mar 6. No abstract available.

PMID:
28264800
10.

Autoinflammatory associated vasculitis.

Ginsberg S, Rosner I, Rozenbaum M, Slobodin G, Zilber K, Boulman N, Kaly L, Awisat A, Jiries N, Beyar-Katz O, Rimar D.

Semin Arthritis Rheum. 2016 Dec;46(3):367-371. doi: 10.1016/j.semarthrit.2016.07.007. Epub 2016 Jul 20.

PMID:
27612399
11.

Evidence Implicating Immunological Host Effects in the Efficacy of Metronomic Low-Dose Chemotherapy.

Shaked Y, Pham E, Hariharan S, Magidey K, Beyar-Katz O, Xu P, Man S, Wu FT, Miller V, Andrews D, Kerbel RS.

Cancer Res. 2016 Oct 15;76(20):5983-5993. Epub 2016 Aug 28.

12.

Peripheral T-cell lymphoma mimicking Schnitzler syndrome.

Beyar Katz O, Schiff E, Rosner I, Tadmor T, Awisat A, Jiries N, Wirsansky I, Ginsberg S.

Int J Rheum Dis. 2017 Dec;20(12):2194-2196. doi: 10.1111/1756-185X.12893. Epub 2016 Jun 20. No abstract available.

PMID:
27321901
13.

Bortezomib-induced pro-inflammatory macrophages as a potential factor limiting anti-tumour efficacy.

Beyar-Katz O, Magidey K, Ben-Tsedek N, Alishekevitz D, Timaner M, Miller V, Lindzen M, Yarden Y, Avivi I, Shaked Y.

J Pathol. 2016 Jul;239(3):262-73. doi: 10.1002/path.4723. Epub 2016 Apr 29.

PMID:
27037906
14.

Analysis of the Stromal Cellular Components of the Solid Tumor Microenvironment Using Flow Cytometry.

Timaner M, Beyar-Katz O, Shaked Y.

Curr Protoc Cell Biol. 2016 Mar 1;70:19.18.1-19.18.12. doi: 10.1002/0471143030.cb1918s70.

PMID:
26930555
15.

Should autotransplantation in acute myeloid leukemia in first complete remission be revisited?

Zuckerman T, Beyar-Katz O, Rowe JM.

Curr Opin Hematol. 2016 Mar;23(2):88-94. doi: 10.1097/MOH.0000000000000212. Review.

PMID:
26825697
16.

Nephrotic syndrome after hematopoietic stem cell transplantation: a single center experience.

Beyar Katz O, Kruzel Davila E, Zuckerman T, Fineman R, Haddad N, Okasha D, Henig I, Rowe JM, Ofran Y.

Minerva Med. 2015 Dec;106(6):355-7. No abstract available.

PMID:
26787650
17.

Adult Nephrotic Syndrome after Hematopoietic Stem Cell Transplantation: Renal Pathology is the Best Predictor of Response to Therapy.

Beyar-Katz O, Davila EK, Zuckerman T, Fineman R, Haddad N, Okasha D, Henig I, Leiba R, Rowe JM, Ofran Y.

Biol Blood Marrow Transplant. 2016 Jun;22(6):975-981. doi: 10.1016/j.bbmt.2015.12.014. Epub 2015 Dec 29. Review.

Supplemental Content

Loading ...
Support Center